Market Overview

Human Microbiome Markets, 2022: The Unavoidable Companion Technological Report and Market Scenario - ResearchAndMarkets.com

Share:

The "Human
Microbiome: The Unavoidable Companion Technological Report and Market
Scenario"
report has been added to ResearchAndMarkets.com's
offering.

The global human microbiome market is nearly expected to grow by $521.23
million in 2022

This report provides an in-depth diverse perspective and the importance
of human microbiome in health and disease-related conditions.
Alterations in human microbiome occur by exposure to various extrinsic
factors like diet, xenobiotics, drugs as well as pathogens which
contribute to the pathogenesis of various metabolic, neurological,
immunological, and cancer-promoting diseases. It will also disclose the
key aspects of the human microbiome as well as the current
biotechnological tools and techniques for studying the human microbiome.

Various human microbial studies are known to identify and categorize the
bacterial taxa and functions that are shared by a majority of
individuals. This report will cover the factors which can affect the
human microbiome as well as various studies which are well known and can
be used as a tool for identifying the potential of the functional
microbiome. It will also emphasize on the various microbiome-based
markers which can be useful in determining the disease or the risk of
disease and various approaches like Fecal Microbiota Transplant (FMT),
Genetically engineered probiotics, etc. which have a profound effect in
improving the microbiome condition.

This report covers its market trends analysis and its growth in the
commercial market. It will also include the major key players like
Agilent technologies, Abbott, Biocartis, etc. which are actively working
in this field and will also be discussed its future market scenario.

Key Topics Covered:

1 Table of Contents

2 Executive Summary

3 Introduction

4 Human Microbiome: Overview

5 Research Scope

6 Research Methodology

7 Research Approach

8 Research Sources

9 Technical Analysis

10 Mode of Administration of Microbiome Products

11 Microbiome Product forms

12 Market Analysis

13 Market Trend Analysis

14 Key Microbiome Players (Company Profiling)

  • 4D Pharma plc
  • Abbott Diagnostics
  • Agilent Technologies Inc.
  • Anaeropharma Science
  • AOBiome, LLC
  • Aperiomics, Inc.
  • Atlas Biomed
  • AvidBiotics
  • Beckman Coulter/Danaher
  • Becton, Dickinson and Company (BD)
  • Biocartis Group
  • C3J Therapeutics (formerly C3 Jian)
  • Crestovo (Finch Therapeutics Group)
  • Danaher Corporation
  • Eppendorf AG
  • Evelo Biosciences
  • Evolve Biosystems
  • Finch Therapeutics Group
  • One Codex
  • OpenBiome
  • Optibiotix
  • OraSure Technologies, Inc.
  • Osel, Inc.
  • PerkinElmer, Inc. (Pe)
  • Pfizer, Inc.
  • Phase Genomics
  • Proderm IQ
  • Prodigest
  • Promega Corporation
  • PureFlora Inc.
  • QIAGEN
  • Quay Pharma
  • Whole Biome
  • Xycrobe Therapeutics, Inc.
  • Zymo Research

For more information about this report visit https://www.researchandmarkets.com/research/4qb2jm/human_microbiome?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

View Comments and Join the Discussion!